NCT03646396View on ClinicalTrials.gov

Effect of Sofosbuvir-daclatasuvir on Angiogenesis

NARecruitingINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

August 31, 2025

Study Completion Date

December 31, 2025

Conditions

HCV Coinfection

Interventions

DRUG

Sofosbuvir-daclatasvir

Sofosbuvir-daclatasvir for 3 months

Trial Locations (1)

Unknown

RECRUITING

Sherief Abd-Elsalam, Tanta

All Listed Sponsors

lead

Sherief Abd-Elsalam

OTHER